Status:
RECRUITING
Dobutamine During Major Abdominal Surgery
Lead Sponsor:
University of Hamburg-Eppendorf
Conditions:
Intraoperative Myocardial Depression
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The PUSH-1 trial is a randomized, single-center pilot trial investigating whether dobutamine administration is feasible in patients having major abdominal surgery.
Eligibility Criteria
Inclusion
- Consenting patients ≥18 years scheduled for elective major abdominal surgery under general anesthesia (expected surgery duration ≥ 120 minutes)
- Planned continuous intraarterial blood pressure monitoring using an arterial catheter for clinical indications not related to the trial
Exclusion
- Emergency surgery
- Liver or kidney transplantation surgery
- Status of post transplantation of kidney, liver, heart, or lung
- Pregnancy
- Heart rhythms other than sinus rhythm
Key Trial Info
Start Date :
June 16 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07000994
Start Date
June 16 2025
End Date
April 1 2026
Last Update
June 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Hamburg-Eppendorf
Hamburg, Hamburg, Germany, 20246